Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study (2012)

First Author: Babiker A
Attributed to:  Adult HIV Clinical Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/1740774512440342

PubMed Identifier: 22547421

Publication URI: http://europepmc.org/abstract/MED/22547421

Type: Journal Article/Review

Parent Publication: Clinical Trials: Journal of the Society for Clinical Trials

Issue: 1_suppl

ISSN: 1740-7745